Safety and tolerability of rituximab in the treatment of systemic sclerosis

Safety and tolerability of rituximab in the treatment of systemic sclerosis

Introduction. Rituximab (RTX) has been used for the treatment of systemic sclerosis (SSс) for a long time and has shown good efficacy for skin fibrosis and interstitial lung disease. However, data on tolerability and long-term adverse events (AEs) during RTX therapy in SSc are insufficient.Objective...

Full description

Saved in:
Bibliographic Details
Main Authors: L. A. Garzanova, L. P. Ananyeva, O. A. Koneva, O. V. Desinova, M. N. Starovoytova, O. B. Ovsyannikova, R. U. Shayakhmetova, S. I. Glukhova
Format: Article
Language:Russian
Published: IMA PRESS LLC 2023-04-01
Series:Научно-практическая ревматология
Subjects:
systemic sclerosis
rituximab
adverse events
Online Access:https://rsp.mediar-press.net/rsp/article/view/3322
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://rsp.mediar-press.net/rsp/article/view/3322

Similar Items